Skip to main content

Genetic Analysis of Animals

A new genetic analysis of animals in the Wuhan market in 2019 may help find COVID-19's origin



Scientists searching for the origins of COVID-19 have zeroed in on a short list of animals that possibly helped spread it to people, an effort they hope could allow them to trace the outbreak back to its source.

Researchers analyzed genetic material gathered from the Chinese market where the first outbreak was detected and found that the most likely animals were racoon dogs, civet cats and bamboo rats. The scientists suspect infected animals were first brought to the Wuhan market in late November 2019, which then triggered the pandemic.

Michael Worobey, one of the new study's authors, said they found which sub-populations of animals might have transmitted the coronavirus to humans. That may help researchers pinpoint where the virus commonly circulates in animals, known as its natural reservoir.

"For example, with the racoon dogs, we can show that the racoon dogs that were (at the market) … were from a sub-species that circulates more in southern parts of China," said Worobey, an evolutionary biologist at the University of Arizona. Knowing that might help researchers understand where those animals came from and where they were sold. Scientists might then start sampling bats in the area, which are known to be the natural reservoirs of related coronaviruses like SARS.


While the research bolsters the case that COVID-19 emerged from animals, it does not resolve the polarized and political debate over whether the virus instead emerged from a research lab in China.

Mark Woolhouse, a professor of infectious diseases at the University of Edinburgh, said the new genetic analysis suggested that the pandemic "had its evolutionary roots in the market" and that it was very unlikely COVID-19 was infecting people before it was identified at the Huanan market.

"It's a significant finding and this does shift the dial more in favor of an animal origin," Woolhouse, who was not connected to the research, said. "But it is not conclusive."

An expert group led by the World Health Organization concluded in 2021 that the virus probably spread to humans from animals and that a lab leak was "extremely unlikely." WHO chief Tedros Adhanom Ghebreyesus later said it was "premature" to rule out a lab leak.


An AP investigation in April found the search for the COVID origins in China has gone dark after political infighting and missed opportunities by local and global health officials to narrow the possibilities.

Scientists say they may never know for sure where exactly the virus came from.

In the new study, published Thursday in the journal Cell, scientists from Europe, the U.S. and Australia analyzed data previously released by experts at the Chinese Center for Disease Control and Prevention. It included 800 samples of genetic material Chinese workers collected on Jan. 1, 2020 from the Huanan seafood market, the day after Wuhan municipal authorities first raised the alarm about an unknown respiratory virus.

Chinese scientists published the genetic sequences they found last year, but did not identify any of the animals possibly infected with the coronavirus. In the new analysis, researchers used a technique that can identify specific organisms from any mixture of genetic material collected in the environment.


Worobey said the information provides "a snapshot of what was (at the market) before the pandemic began" and that genetic analyses like theirs "helps to fill in the blanks of how the virus might have first started spreading."

Woolhouse said the new study, while significant, left some critical issues unanswered.

"There is no question COVID was circulating at that market, which was full of animals," he said. "The question that still remains is how it got there in the first place."

Wuhan market, COVID-19 origin, genetic analysis, wildlife trade, animal species, raccoon dogs, intermediary hosts, genomic data, SARS-CoV-2-like viruses, zoonotic spillover, genetic makeup, human COVID-19 cases, evolutionary lineage, viral reservoirs, wet markets, cross-species transmission, coronaviruses, epidemiological patterns, wildlife-to-human transmission, outbreak prevention.

#WuhanMarket, #COVID19Origin, #GeneticAnalysis, #WildlifeTrade, #RaccoonDogs, #IntermediaryHosts, #SARSCoV2, #ZoonoticSpillover, #GenomicData, #ViralEvolution, #AnimalSpecies, #CrossSpeciesTransmission, #PandemicOrigins, #ViralReservoirs, #Coronaviruses, #WetMarkets, #Epidemiology, #WildlifeToHuman, #OutbreakPrevention, #VirusOrigins.

International Conference on Genetics and Genomics of Diseases 




For Enquiries: genetics@healthcarek.com 

Get Connected Here 
--------------------------------- 
--------------------------------- 

Comments

Post a Comment

Popular posts from this blog

Fruitful innovation

Fruitful innovation: Transforming watermelon genetics with advanced base editors The development of new adenine base editors (ABE) and adenine-to-thymine/ guanine base editors (AKBE) is transforming watermelon genetic engineering. These innovative tools enable precise A:T-to-G and A:T-to-T base substitutions, allowing for targeted genetic modifications. The research highlights the efficiency of these editors in generating specific mutations, such as a flowerless phenotype in ClFT (Y84H) mutant plants. This advancement not only enhances the understanding of gene function but also significantly improves molecular breeding, paving the way for more efficient watermelon crop improvement. Traditional breeding methods for watermelon often face challenges in achieving desired genetic traits efficiently and accurately. While CRISPR/Cas9 has provided a powerful tool for genome editing, its precision and scope are sometimes limited. These limitations highlight the need for more advanced gene-e...
Post a Comment
Read more

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...
Post a Comment
Read more

Genetics study on COVID-19

Large genetic study on severe COVID-19 Bonn researchers confirm three other genes for increased risk in addition to the known TLR7 gene Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in cooperation with other research teams from Germany, the Netherlands, Spain and Italy, investigated a particularly large group of affected individuals. They confirmed the central and already known role of the TLR7 gene in severe courses of the disease in men, but were also able to find evidence for a contribution of the gene in women. In addition, they were able to show that genetic changes in three other genes of the innate immune system contribute to severe COVID-19. The results have now been published in the journal " Human Genetics and Genomics Advances ". Even though the number of severe cases following infection with the SARS-CoV-...
Post a Comment
Read more